檢索結果 - Shani Paluch‐Shimon
- Showing 1 - 20 results of 41
- Go to Next Page
-
1
-
2
Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening 由 Shani Paluch‐Shimon, Fátima Cardoso, Cristiana Sessa, Judith Balmañà, Maria João Cardoso, Fiona J. Gilbert, Elżbieta Senkus
出版 2016Artigo -
3
-
4
153P Adjuvant endocrine therapy combined with abemaciclib in monarchE patients with high-risk early breast cancer: Disease characteristics and endocrine therapy choice by menopausa... 由 Shani Paluch‐Shimon, H-J Lueck, Jane Beith, Eriko Tokunaga, Jessica Reyes Contreras, RC Santana, Tammy Forrester, Rhian McNaughton, Jennifer Wei, Nadia Harbeck
出版 2021Artigo -
5
Moderate penetrance genes complicate genetic testing for breast cancer diagnosis: ATM, CHEK2, BARD1 and RAD51D 由 Rossella Graffeo, Huma Q. Rana, Fabio Conforti, Bernardo Bonanni, Maria João Cardoso, Shani Paluch–Shimon, Olivia Pagani, Aron Goldhirsch, Ann H. Partridge, Matteo Lambertini, Judy E. Garber
出版 2022Revisão -
6
ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast Cancer 由 Evandro de Azambuja, Dario Trapani, Sibylle Loibl, Suzette Delaloge, Elżbieta Senkus, Carmen Criscitiello, Philip Poortmans, Michael Gnant, Serena Di Cosimo, Javier Cortés, Fátima Cardoso, Shani Paluch‐Shimon, Giuseppe Curigliano
出版 2020Revisão -
7
The BCY3/BCC 2017 survey on physicians' knowledge, attitudes and practice towards fertility and pregnancy-related issues in young breast cancer patients 由 Matteo Lambertini, Massimo Di Maïo, Olivia Pagani, Giuseppe Curigliano, Francesca Poggio, Lucia Del Mastro, Shani Paluch–Shimon, Sibylle Loibl, Ann H. Partridge, Isabelle Demeestere, Hatem A. Azim, Fedro A. Peccatori
出版 2018Artigo -
8
Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice Guidelines† 由 Matteo Lambertini, Fedro A. Peccatori, Isabelle Demeestere, Frédéric Amant, Christine Wyns, Jan‐Bernd Stukenborg, Shani Paluch–Shimon, M Halaška, Catherine Uzan, Julia Meißner, Michael von Wolff, Richard A. Anderson, Karin Jordan
出版 2020Artigo -
9
Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers 由 Talia Golan, Zaheer Kanji, Ron Epelbaum, Nicholas Devaud, Efrat Dagan, Spring Holter, Dan Aderka, Shani Paluch‐Shimon, Brett A. Kaufman, Ruth Gershoni‐Baruch, David W. Hedley, Malcolm J. Moore, Eitan Friedman, Steven Gallinger
出版 2014Artigo -
10
LBA15 MONARCH 3: Interim overall survival (OS) results of abemaciclib plus a nonsteroidal aromatase inhibitor (NSAI) in patients (pts) with HR+, HER2- advanced breast cancer (ABC) 由 M.P. Goetz, M. Toi, J. Huober, J. Sohn, O. Tredan, I.H. Park, M. Campone, S.C. Chen, L.M. Manso Sanchez, Shani- Paluch–Shimon, G. van Hal, A. Shahir, H. Iwata, S. Johnston
出版 2022Artigo -
11
Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment... 由 Dror Meirow, Hila Raanani, Ettie Maman, Shani Paluch–Shimon, Moran Shapira, Yoram Cohen, Irena Kuchuk, Ariel Hourvitz, Jacob Levron, Michal Mozer-Mendel, Masha Brengauz, Hana Biderman, Daphna Manela, Rephael Catane, Jehoshua Dor, Raoul Orvieto, Bella Kaufman
出版 2014Artigo -
12
Second international consensus guidelines for breast cancer in young women (BCY2) 由 Shani Paluch–Shimon, Olivia Pagani, Ann H. Partridge, Eran Bar‐Meir, Lesley Fallowfield, Deborah Fenlon, Eitan Friedman, Karen A. Gelmon, Oreste Gentilini, James Geraghty, Nadia Harbeck, Stephen P. Higgins, Sibylle Loibl, Elizabeth Charlotte Moser, Fedro A. Peccatori, Hila Raanani, Bella Kaufman, Fátima Cardoso
出版 2016Artigo -
13
ESO–ESMO 4th International Consensus Guidelines for Breast Cancer in Young Women (BCY4) 由 Shani Paluch–Shimon, Fátima Cardoso, Ann H. Partridge, Omalkhair Abulkhair, Hatem A. Azim, G. Bianchi-Micheli, Maria João Cardoso, Giuseppe Curigliano, Karen A. Gelmon, Nadia Harbeck, J. Merschdorf, Philip Poortmans, Giancarlo Pruneri, Elżbieta Senkus, Tanja Španić, Vered Stearns, Yvonne Wengström, Fedro A. Peccatori, Olivia Pagani
出版 2020Artigo -
14
Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline 由 Cristiana Sessa, Judith Balmañà, Sharon L. Bober, Maria João Cardoso, N. Colombo, Giuseppe Curigliano, Susan M. Domchek, D. Gareth Evans, D. Fischerová, Nadia Harbeck, Christiane Kühl, Birthe Lemley, Ephrat Levy‐Lahad, Matteo Lambertini, Jonathan A. Ledermann, Sibylle Loibl, Kelly‐Anne Phillips, Shani Paluch‐Shimon
出版 2022Artigo -
15
Efficacy and safety results by menopausal status in monarchE: adjuvant abemaciclib combined with endocrine therapy in patients with HR+, HER2−, node-positive, high-risk early breas... 由 Shani Paluch‐Shimon, Patrick Neven, Jens Huober, İrfan Çiçin, Matthew P. Goetz, Chikako Shimizu, Chiun‐Sheng Huang, Hans Joachim Lueck, Jane Beith, Eriko Tokunaga, Jessica Reyes Contreras, Rosane Oliveira Sant'Ana, Ran Wei, Ashwin Shahir, Sarah C. Nabinger, Tammy Forrester, Stephen Johnston, Nadia Harbeck
出版 2023Artigo -
16
Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study 由 Sylvia Adams, P. Schmid, H. S. Rugo, EP Winer, D. Loirat, Ahmad Awada, D.W. Cescon, Hiromitsu Iwata, M. Campone, Rita Nanda, Rita L. Hui, Giuseppe Curigliano, D. Toppmeyer, Joyce O’Shaughnessy, Sherene Loi, Shani Paluch‐Shimon, Antoinette R. Tan, Deborah Card, Jing Zhao, V. Karantza, Javier Cortés
出版 2018Artigo -
17
Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancer 由 Stefan Michiels, Lina Pugliano, Sophie Marguet, Daniel Grun, Jana Barinoff, David Cameron, Melody A. Cobleigh, Angelo Di Leo, S. Johnston, Giulio Gasparini, Bella Kaufman, M Marty, Valentina Nekljudova, Shani Paluch–Shimon, F Penault–Llorca, Dennis J. Slamon, Charles L. Vogel, Gϋnter von Minckwitz, Marc Buyse, Martine Piccart
出版 2016Artigo -
18
Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breas... 由 Gabriel N. Hortobágyi, Salomon M. Stemmer, H. A. Burris, Yoon Sim Yap, Gabe S. Sonke, Shani Paluch‐Shimon, Mario Campone, Katarína Petráková, Kim T. Blackwell, Eric P. Winer, W Janni, S. Verma, Pierfranco Conté, Carlos L. Arteaga, David Cameron, S. Mondal, Faye Su, Marshall G. Miller, Mohamed Elmeliegy, Caroline Germa, Joyce O’Shaughnessy
出版 2018Artigo -
19
Physicians’ knowledge, practice, and attitudes on fertility and pregnancy-related issues in young women with advanced breast cancer: results of the ABC6 and ABC7 survey 由 Simone Nardin, Luca Arecco, Virginia Delucchi, Eva Blondeaux, Mihaela Stana, Luciana de Moura Leite, Luiza Nardin Weis, Giang Pham Hoang, Arianna Daneri, F. Bruzzone, Arianna Meacci, Chiara Molinelli, Maria Grazia Razeti, Martina Perrone, Shani Paluch‐Shimon, Ann H. Partridge, Fátima Cardoso, Tanja Španić, Joanna Kufel-Grabowska, Matteo Lambertini
出版 2025Artigo -
20
Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breas... 由 Gabriel N. Hortobágyi, Salomon M. Stemmer, H.A. Burris, Yoon Sim Yap, Gabe S. Sonke, Shani Paluch–Shimon, M. Campone, Katarína Petráková, Kimberly Blackwell, Eric P. Winer, W Janni, Sunil Verma, Pierfranco Conté, Carlos L. Arteaga, David Cameron, S. Mondal, Fei Su, Marshall G. Miller, Mohamed Elmeliegy, Caroline Germa, Joyce O’Shaughnessy
出版 2019Errata/Corrigenda
相關主題
Cancer
Breast cancer
Internal medicine
Medicine
Oncology
Gynecology
Biology
Family medicine
Genetics
Pathology
Confidence interval
Environmental health
Hazard ratio
Population
Metastatic breast cancer
Pregnancy
Fertility
Gene
Obstetrics
Consensus conference
Guideline
Tamoxifen
Alternative medicine
Clinical Practice
Clinical endpoint
Cohort
Fertility preservation
Genetic testing
Hormone receptor
Interim analysis